Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

epinephrine

NEFFY

epinephrine (NEFFY) is a adrenergic receptor agonist. Associated with Ars Pharmaceuticals Irl Limited. Route of administration: intravenous, intraocular, intramuscular, subcuta. Current US regulatory status: approved.

FDA: approved EMA: approved Cardiovascular system (C01) C01CA24
US status approved
Patents linked 20
Pipeline programs 45
News articles 1
Drug details — epinephrine
US status
approved
Class
Cardiovascular system (C01)
Route
INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTA
Patents
20
Programs
45
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

epinephrine (NEFFY) is a adrenergic receptor agonist. Associated with Ars Pharmaceuticals Irl Limited. Route of administration: intravenous, intraocular, intramuscular, subcuta. Current US regulatory status: approved.

Key facts

INN epinephrine
Brand NEFFY
Mechanism Adrenergic receptor agonist
Target Adrenergic receptor
Therapeutic class Cardiovascular system (C01)
Route INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTA
Formulation PATCH
ATC code C01CA24
Originator Ars Pharmaceuticals Irl Limited

Mechanism of action

Adrenergic receptor agonist

Primary target: Adrenergic receptor

Approval history

Authority Status Date
FDA approved —
EMA approved —

Recent coverage

View all news
FDA Approves Generic EpiPen: Key Details on Mylan’s Price Solution
High impact NewsallergyApr 19, 2026

FDA Approves Generic EpiPen: Key Details on Mylan’s Price Solution

FDA · allergy · 3 min

The FDA has approved a generic version of EpiPen, providing a more affordable option for individuals needing emergency treatment for severe allergic reactions.

Dr. Sarah Mitchell

Pipeline programs

Search pipeline Sponsor programs
  1. APHP220827 Phase 3 · PARItec · Acute Kidney Injury, Liver transplantation
  2. CHRD 2419 Phase 3 · Novo Nordisk A/S · Cardiorespiratory arrest at birth in full-term newborns
  3. E004 (Epinephrine Inhalation Aerosol) HFA-MDI Phase 3 · Amphastar France Pharmaceuticals · Asthma
  4. Epinephrine Phase 3 · Chinese University of · Gastric Neoplasm
  5. Epinephrine HFA-MDI (E004) Phase 3 · Amphastar France Pharmaceuticals · Asthma
  6. IIBSP-IPV-2024-178 Phase 3 · George Institute for · lumbar arthrodesis
  7. NORADRENALINA TARTRATO MONICO 2 mg/ml Concentrato per soluzione per infusione Phase 3 · Anaxis Pharma · criticall illness
  8. SL0044 Phase 3 · Anaxis Pharma · Systemic lupus erythematosus (SLE)

Related & competitor drugs

Browse all drugs
  1. acebutolol hydrochloride Beta-1 adrenergic receptor antagonist
  2. albuterol Beta-2 adrenergic receptor agonist
  3. albuterol sulfate Beta-2 adrenergic receptor agonist
  4. alirocumab Cardiovascular system (C10)
  5. aliskiren Cardiovascular system (C09)
  6. arformoterol tartrate Beta-2 adrenergic receptor agonist

Related patents

Browse patents Ars Pharmaceuticals Irl Limited patent hub

  1. EP 4732903

    COKRISTALLE VON PITOLISTANTHYDROCHLORID

    Expires Tue Apr 24 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12427121

    Enhanced delivery epinephrine compositions

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12023309

    Enhanced delivery epinephrine compositions

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. EP 4302750

    ORALE DÜNNFILME ENTHALTEND ADRENALIN

    Expires Tue Jan 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11266611

    More potent and less toxic formulations of epinephrine and methods of medical use

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11191737

    Enhanced delivery epinephrine compositions

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 2020024256

    TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

    Expires Wed Jan 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. EP 3378477

    NEUE THERAPEUTISCHE VERWENDUNGEN VON H3-LIGANDEN

    Expires Tue Sep 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8367734

    Stable epinephrine suspension formulation with high inhalation delivery efficiency

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. EP 2014653

    Neue Dicarbonsäurederivate als S1P1 Rezeptor Agonisten

    Expires Tue Jan 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 6759396

    Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid

    Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6593359

    Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6515021

    Bicyclic aromatic compounds

    Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6506796

    Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

    Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6368608

    Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof

    Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6326510

    Bi-aromatic compounds, compositions containing them and uses

    Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6313162

    Propynyl or dienyl biaromatic compounds

    Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6297290

    Composition containing a nerve fiber reactivity modulating compound

    Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6287549

    Method for removing superfluous hairs

    Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6258775

    Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses

    Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is epinephrine?

epinephrine (NEFFY) is a adrenergic receptor agonist. Associated with Ars Pharmaceuticals Irl Limited. Route of administration: intravenous, intraocular, intramuscular, subcuta. Current US regulatory status: approved.

What is the brand name for epinephrine?

NEFFY is a marketed brand name for epinephrine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of epinephrine?

epinephrine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.